Costigmine 0.5mg/2.5mg Injection
Marketer
Miracalus Pharma Pvt Ltd
Salt Composition
Glycopyrrolate (0.5mg) + Neostigmine (2.5mg)
Overview Costigmine 0.5mg/2.5mg Injection
Neostigmine and atropine injection (0.5mg/2.5mg) is a dual-action medication administered during surgical procedures under anesthesia. Administration is performed by a qualified medical professional, with dosage tailored to individual patient needs and response. Complete disclosure of all other medications to your healthcare provider is crucial due to potential interactions. Allergic reactions are the most frequently reported adverse effect; these are typically transient and self-limiting. Report any concerns regarding side effects immediately to your doctor. Drowsiness and lightheadedness are possible; therefore, refrain from operating machinery or driving until the effects are known. Alcohol consumption should be avoided as it may exacerbate dizziness. Prior to treatment, inform your physician about pregnancy, pregnancy planning, breastfeeding, and any existing kidney, liver, or gastrointestinal conditions to ensure appropriate dosage.
Uses of Costigmine 0.5mg/2.5mg Injection
Counteracting the pharmacological impact of specific surgical agents
Major Benefits of Costigmine 0.5mg/2.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Costigmine 0.5mg/2.5mg Injection:
- Allergic reaction
How to use Costigmine 0.5mg/2.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Costigmine 0.5mg/2.5mg Injection works:
Neostigmine and glycopyrrolate, at doses of 0.5mg and 2.5mg respectively, are combined in Costigmine Injection.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Costigmine 0.5mg/2.5mg Injection and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Neostigmine 0.5mg/2.5mg Injection might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Costigmine 0.5mg/2.5mg Injection during breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, prolonged administration of Costigmine 0.5mg/2.5mg Injection may decrease breast milk supply.
DrivingUNSAFE
Administration of Costigmine 0.5mg/2.5mg Injection may induce adverse reactions that can impair driving capabilities. Visual disturbances and impaired coordination, potential consequences of Costigmine 0.5mg/2.5mg Injection, may compromise driving safety.
KidneyCAUTION
Patients with kidney impairment should use Costigmine 0.5mg/2.5mg Injection cautiously, as dose modification may be necessary. Physician consultation is recommended. Routine monitoring of renal function and certain blood parameters may be advised during treatment.
LiverSAFE IF PRESCRIBED
Individuals with hepatic impairment may likely tolerate Costigmine 0.5mg/2.5mg Injection without harm. Existing evidence indicates dose modification for this patient group may be unnecessary. Physician consultation is advised.
What if you forget to take Costigmine 0.5mg/2.5mg Injection :
Omitting a scheduled dose of Costigmine 0.5mg/2.5mg Injection warrants immediate physician consultation.
Facts to Know About Costigmine 0.5mg/2.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
3,018 People bought this recently